|
|
|
|
|
|
|
|
02.06.25 - 14:06
|
Lightcast Appoints Industry Veteran Philip Binns as Chairman of the Board (Business Wire)
|
|
Former Agilent executive to help guide commercial growth strategies for groundbreaking benchtop single-cell functional analysis platformCAMBRIDGE, England & CAMBRIDGE, Mass.--(BUSINESS WIRE)--#AntibodyDiscovery--Lightcast, a pioneering life science tools company, today announced the appointment of Philip Binns as chairman of its board of directors, effective May 1, 2025. With this appointment, the Lightcast board includes one investor director each from Arch Ventures, Illumina Ventures, M-Ventures, and Longwall Ventures; two independent directors, Kevin Knopp, CEO of 908 Devices, and Kevin Hrusovsky, chairman and former CEO of Quanterix; and observers from OMX Ventures, +ND Capital, and Terra Magnum.
"We are thrilled to add Phil to our highly experienced board," said Paul Loeffen, PhD, CEO of Lightcast. "His extensive industry expertise and proven leadership will be invaluable as we evolve from a product development-focused company into a fully commercial organization, expanding our global ...
|
|
|
|
|
|
|
28.05.25 - 23:01
|
Agilent Technologies Profit Retreats In Q2 (AFX)
|
|
SANTA CLARA (dpa-AFX) - Agilent Technologies (A) revealed earnings for second quarter that decreased from the same period last yearThe company's bottom line came in at $215 million, or $0.75 per s......
|
|
|
|
28.05.25 - 22:09
|
Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results (Business Wire)
|
|
Agilent delivers strong quarter, enabled by Ignite Transformation
Highlights
Revenue of $1.67 billion for the second quarter ended April 30, 2025, representing growth of 6.0% reported and up 5.3% on a core(1) basis compared with the second quarter of 2024.
GAAP net income of $215 million; earnings per share (EPS) of $0.75, down 29% from the second quarter of 2024.
Non-GAAP(2) net income of $373 million; EPS of $1.31, up 7% from the second quarter of 2024.
Outlook for full 2025 fiscal year and Q3
Full-year revenue outlook is now in the range of $6.73 billion to $6.81 billion, representing a range of up 3.4% to 4.6% reported, while maintaining 2.5% to 3.5% core(1). Non-GAAP EPS(3) is expected in the range of $5.54 to $5.61.
Q3 revenue outlook is expected to be in the range of $1.645 billion to $1.675 billion, an increase of 4.2% to 6.1% reported and up 1.7% to 3.6% core(1). Non-GAAP EPS(3) is expected in the range of $1.35 to $1.37 per share.
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (...
|
|
28.05.25 - 14:33
|
Agilent Names August Specht as Chief Technology Officer (Business Wire)
|
|
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced August Specht, Ph.D., has been named the company's Chief Technology Officer. Specht, previously vice president of Global R&D for the Chromatography and Mass Spectrometry Division at Thermo Fisher Scientific, will join Agilent on June 9.
“We are thrilled to welcome August Specht to the Agilent team as we further accelerate the pace of innovation in an ever-changing world through our Ignite Transformation,” said Padraig McDonnell, Agilent president and CEO. “August brings more than 25 years of experience designing, developing, and marketing analytical instruments, software, and consumables that support scientific advancement around the world. His work reflects a deep understanding of the scientific community's evolving needs and a commitment to delivering innovative solutions that help customers bring great science to life.”
Prior to his role as vice president of Global R&D for the Chromatography and Mass Spe...
|
|
|
|